Production & Manufacturing

Bicycle Therapeutics has entered into a 15-year agreement with the UK Nuclear Decommissioning Authority (NDA) to utilize reprocessed uranium from nuclear reactors for the production of precision cancer therapies. Under the terms of the deal, announced by the UK government,...

Pfizer has confirmed that it has struck an almost $2.1bn licensing deal with YaoPharma in order to develop as well as commercialize its obesity pill, hence furthering its push into the weight loss spectrum. It is worth noting that the...

The European Commission has stepped up and given the nod to €47 million in German state aid for Vetter Pharma, which is a German pharmaceutical service provider. The aid is going to support the establishment when it comes to a new aseptic filling...

With an intent to make the incurable curable, Huntsville may as well become the right place of biopharma production in the next decade. Eli Lilly, the pharmaceutical giant, announced plans on December 9, 2025, to invest over $6bn on the...

Bora Pharmaceuticals Co. Ltd., which is a global leader when it comes to pharmaceutical manufacturing, along with a leading early-phase Contract Development Manufacturing Organization – CDMO, Corealis Pharma Inc., have gone on to enter into a strategic alliance so...

Iraq looks forward to inaugurating the region’s largest cancer drug factory in Abu Ghraib, which is situated 32 kilometers – equivalent to 20 miles west of Baghdad, in December 2025 at a cost of around 50 million euros. This step...

Samsung Biologics announced on November 26, 2025, that it has gone on to achieve a whopping 400 regulatory manufacturing approvals all over the world due to its quality competitiveness. It is worth noting that as of November 2025, Samsung Biologics has secured...